Pfizer's experimental oral drug to treat Covid-19 at the first sign of illness could be available by the end of the year, CEO Albert Bourla told CNBC on Tuesday.- The drug is part of a class of medicines called protease inhibitors and works by inhibiting an enzyme that the virus needs to replicate in human cells.
- Protease inhibitors are used to treat other viral pathogens such as HIV and hepatitis C.
No comments:
Post a Comment